TY -的T1 Mesothelin和骨桥蛋白摩根富林明——欧元opean Respiratory Journal JO - Eur Respir J SP - 557 LP - 558 DO - 10.1183/09031936.00064413 VL - 42 IS - 2 AU - Pantazopoulos, Ioannis AU - Xanthos, Theodoros AU - Boura, Paraskevi AU - Syrigos, Konstantinos Y1 - 2013/08/01 UR - //www.qdcxjkg.com/content/42/2/557.2.abstract N2 - From the Authors:We would like to thank Gunnar Hillerdal for his interest in our article 1 and for giving us the opportunity to make some comments regarding multimodality therapy and early stage disease.Sugarbaker et al. 2 reported a groundbreaking result in 1999: patients with early stage malignant pleural mesothelioma (MPM) had a 5-year survival rate after trimodality therapy that exceeded 40%. Since then, there have been a number of subsequent prospective and retrospective series, which have all demonstrated a median … ER -